Kv7 voltage-activated potassium channel inhibitors reduce fluid resuscitation requirements after hemorrhagic shock in rats
Open Access
- 17 January 2017
- journal article
- research article
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 24 (1) , 1-8
Abstract
Recent evidence suggests that drugs targeting Kv7 channels could be used to modulate vascular function and blood pressure. Here, we studied whether Kv7 channel inhibitors can be utilized to stabilize hemodynamics and reduce resuscitation fluid requirements after hemorrhagic shock. Anesthetized male Sprague-Dawley rats were instrumented with arterial and venous catheters for blood pressure monitoring, hemorrhage and fluid resuscitation. Series 1: Linopirdine (Kv7 channel blocker, 0.1–6 mg/kg) or retigabine (Kv7 channel activator, 0.1–12 mg/kg) were administered to normal animals. Series 2: Animals were hemorrhaged to a MAP of 25 mmHg for 30 min, followed by fluid resuscitation with normal saline (NS) to a MAP of 70 mmHg until t = 75 min. Animals were treated with single bolus injections of vehicle, linopirdine (1–6 mg/kg), XE-991 (structural analogue of linopirdine with higher potency for channel blockade, 1 mg/kg) prior to fluid resuscitation. Series 3: Animals were resuscitated with NS alone or NS supplemented with linopirdine (1.25–200 μg/mL). Data were analyzed with 2-way ANOVA/Bonferroni post-hoc testing. Series 1: Linopirdine transiently (10–15 min) and dose-dependently increased MAP by up to 15%. Retigabine dose-dependently reduced MAP by up to 60%, which could be reverted with linopirdine. Series 2: Fluid requirements to maintain MAP at 70 mmHg were 65 ± 34 mL/kg with vehicle, and 57 ± 13 mL/kg, 22 ± 8 mL/kg and 22 ± 11 mL/kg with intravenous bolus injection of 1, 3 and 6 mg/kg linopirdine, respectively. XE-991 (1 mg/kg), reduced resuscitation requirements comparable to 3 mg/kg linopirdine. Series 3: When resuscitation was performed with linopirdine-supplemented normal saline (NS), fluid requirements to stabilize MAP were 73 ± 12 mL/kg with NS alone and 72 ± 24, 61 ± 20, 36 ± 9 and 31 ± 9 mL/kg with NS supplemented with 1.25, 6.25, 12.5 and 200 μg/mL linopirdine, respectively. Our data suggest that Kv7 channel blockers could be used to stabilize blood pressure and reduce fluid resuscitation requirements after hemorrhagic shock.Keywords
Funding Information
- National Institute of General Medical Sciences (R01GM107495, T32GM008750)
This publication has 29 references indexed in Scilit:
- Novel treatment strategies for smooth muscle disorders: Targeting Kv7 potassium channelsPharmacology & Therapeutics, 2016
- Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practiceAnaesthesiology Intensive Therapy, 2014
- Hypotensive ResuscitationCurrent Anesthesiology Reports, 2014
- Resuscitative strategies in traumatic hemorrhagic shockAnnals of Intensive Care, 2013
- Arginine vasopressin: The future of pressure-support resuscitation in hemorrhagic shockJournal of Surgical Research, 2012
- San Antonio Vasopressin in Shock Symposium ReportResuscitation, 2010
- Deaths: final data for 2006.2009
- Cardiovascular KCNQ (Kv7) Potassium Channels: Physiological Regulators and New Targets for Therapeutic InterventionMolecular Pharmacology, 2008
- Secondary Abdominal Compartment Syndrome After Severe Extremity Injury: Are Early, Aggressive Fluid Resuscitation Strategies to Blame?Journal of Trauma: Injury, Infection & Critical Care, 2008
- Impact of Hemorrhage on Trauma Outcome: An Overview of Epidemiology, Clinical Presentations, and Therapeutic ConsiderationsJournal of Trauma: Injury, Infection & Critical Care, 2006